VYNDAQEL

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Turkey, United Kingdom, United States

Active ingredients

The drug VYNDAQEL contains one active pharmaceutical ingredient (API):

1 Tafamidis UNII ZU7CF08A1A - TAFAMIDIS MEGLUMINE

Tafamidis is a selective stabiliser of transthyretin (TTR). Tafamidis binds to TTR at the thyroxine binding sites, stabilising the tetramer and slowing dissociation into monomers, the rate-limiting step in the pathogenesis of transthyretin amyloidosis. Read about Tafamidis

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VYNDAQEL 20 mg Soft capsule	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N07XX08	Tafamidis	N Nervous system → N07 Other nervous system drugs → N07X Other nervous system drugs → N07XX Other nervous system drugs
Discover more medicines within N07XX08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 522720030084717, 522720050085407
Country: CA	Health Products and Food Branch	Identifier(s): 02495732
Country: EE	Ravimiamet	Identifier(s): 1549751, 1684548, 1811630, 1811641
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 11717001, 11717001IP
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 144490, 541372
Country: FR	Base de données publique des médicaments	Identifier(s): 61420887, 66376626
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 221123, 385293
Country: HK	Department of Health Drug Office	Identifier(s): 65208
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7750
Country: IT	Agenzia del Farmaco	Identifier(s): 041663016, 041663028, 041663030
Country: JP	医薬品医療機器総合機構	Identifier(s): 1290001M1022
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1063738, 1076647, 1089462, 1089463
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100262375, 100433842
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64784002, W64784003, W66576001
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681308191007
Country: US	FDA, National Drug Code	Identifier(s): 0069-1975